ERIC 2018 | The future of CLL: managing new toxicities and improved categorization

Daniel Catovsky

Despite extraordinary advancements, there are still improvements to be made in the chronic lymphocytic leukemia (CLL) space. Speaking from the European Research Initiative on CLL (ERIC) International Meeting 2018, held in Barcelona, Spain, Daniel Catovsky, MD, DSc, FRCP, FRCPath, FMedSci, of the Institute of Cancer Research, London, UK, gives us his perspective on the future of CLL.

Share this video